Straight answers on patient recruitment
For sponsors and clinical ops teams · No gated PDFs, no email walls
Nearly 85% of interventional trials miss their enrollment milestones. These guides cover what actually moves enrollment, what recruitment really costs, and how to evaluate vendors, including us.
A real funnel, start to finish: 19,715 web screens down to the randomizations, with every conversion rate published.
Why finding rare patients takes consumer-scale outreach, and what the machine looks like when it’s built right.
The five pricing models, the cost drivers hiding in your protocol, and how to compare quotes on the only number that matters.
Marketplaces, ad agencies, communities, data mining, and success-based recruitment: which model fits which trial, including where each one beats us.
When your CRO’s recruitment plan is enough, when a specialist earns the added vendor, and the incentive question that decides it.
Ten questions that separate enrollment partners from referral printers, plus the contract terms that keep everyone honest.
Seven fixes ranked by impact, starting with the one that costs nothing: answering interested patients before their interest cools.
Layered screening that catches disqualifiers before the site visit, and the incentive problem that keeps screen fails high.
32% of our enrollees come from under-represented populations. Not a side program: outreach that goes where patients actually are.
When the eligible population is a few thousand scattered people, recruitment becomes a search-and-trust problem. What works.
A practical sequence for finding the real leak, triaging sites, and knowing when to change course.
Enrollment on the line?
Most firms recruit patients. We deliver enrollments. We take ownership of the whole path, from first click to site visit, and we only get paid when patients enroll.